» Articles » PMID: 22773997

Optical Coherence Tomography Assessed Retinal Nerve Fiber Layer Thickness in Patients with Alzheimer's Disease: a Meta-analysis

Overview
Specialty Ophthalmology
Date 2012 Jul 10
PMID 22773997
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the difference of retinal nerve fiber layer (RNFL) thickness between Alzheimer's disease patients and normal people, so as to provide clue for the early diagnosis of Alzheimer's disease.

Methods: The articles on the association of RNFL thickness and Alzheimer's disease were retrieved by searching international and national databases. The qualified articles were assessed by meta analysis with Stata11.0 software. The results were pooled using weighted mean difference (WMD) with a corresponding 95% confidence interval (CI).

Results: Totally 7 studies enrolled 324 eyes were included in the meta-analysis. The results of meta analysis showed that in AD patients, there was a significant average RNFL thickness reduction compared with the control group [WMD=-17.561, 95%CI: (-23.971, -11.151)]. There were significant differences in superior, inferior, nasal and temporal RNFL thickness between the two groups. WMD with a 95%CI were [-18.829, 95%CI:(-25.915, -11.743); P<0.05], [-25.775, 95%CI:(-34.304, -17.247); P<0.05], [-16.877, 95%CI: (-29.141, -4.613); P<0.001] and [-14.565, 95%CI:(-28.002, -1.128); P<0.001] respectively. Begg's test and Egger's test did not show significant difference, funnel plot was basically symmetrical, indicating that there was no publication bias existed.

Conclusion: There are significant differences in the RNFL thickness in all quadrants between the two groups. RNFL thickness is reduced in AD patients compared with the control group.

Citing Articles

Retinal Ganglion Cell Complex in Alzheimer Disease: Comparing Ganglion Cell Complex and Central Macular Thickness in Alzheimer Disease and Healthy Subjects Using Spectral Domain-Optical Coherence Tomography.

Farzinvash Z, Abutorabi-Zarchi M, Manaviat M, Zare Mehrjerdi H Basic Clin Neurosci. 2023; 13(5):675-684.

PMID: 37313022 PMC: 10258592. DOI: 10.32598/bcn.2021.2040.1.


Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.

Mathew S, WuDunn D, Mackay D, Vosmeier A, Tallman E, Deardorff R J Alzheimers Dis. 2022; 91(2):743-752.

PMID: 36502316 PMC: 9990456. DOI: 10.3233/JAD-210533.


Correlation Between Retrograde Trans-Synaptic Degeneration of Ganglion Cells and Optical Coherence Tomography Angiography Following Ischemic Stroke.

Molero-Senosiain M, Vidal-Villegas B, Pascual-Prieto J, Valor-Suarez C, Saenz-Frances F, Santos-Bueso E Cureus. 2021; 13(11):e19788.

PMID: 34956781 PMC: 8693543. DOI: 10.7759/cureus.19788.


Visual impairment increases the risk of dementia, especially in young males in a 12-year longitudinal follow-up study of a national cohort.

Lee G, Chi S, Kim K, Seo S, Kim H, Chung T Sci Rep. 2021; 11(1):11393.

PMID: 34059787 PMC: 8167134. DOI: 10.1038/s41598-021-91026-4.


Reflections on the Utility of the Retina as a Biomarker for Alzheimer's Disease: A Literature Review.

Ngolab J, Honma P, Rissman R Neurol Ther. 2019; 8(Suppl 2):57-72.

PMID: 31833024 PMC: 6908534. DOI: 10.1007/s40120-019-00173-4.


References
1.
Iseri P, Altinas O, Tokay T, Yuksel N . Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006; 26(1):18-24. DOI: 10.1097/01.wno.0000204645.56873.26. View

2.
Berisha F, Feke G, Trempe C, McMeel J, Schepens C . Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007; 48(5):2285-9. DOI: 10.1167/iovs.06-1029. View

3.
Kesler A, Vakhapova V, Korczyn A, Naftaliev E, Neudorfer M . Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg. 2011; 113(7):523-6. DOI: 10.1016/j.clineuro.2011.02.014. View

4.
Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci M, Pierelli F . Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol. 2001; 112(10):1860-7. DOI: 10.1016/s1388-2457(01)00620-4. View

5.
Petersen R . Mild cognitive impairment. Lancet. 2006; 367(9527):1979. DOI: 10.1016/S0140-6736(06)68881-8. View